# Abhinav Shukla

> Abhinav Shukla is a startup investor at Redpin Therapeutics. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Redpin Therapeutics](https://shizune.co/investors/profile/redpin-therapeutics)
- Last updated: Aug 2026

Abhinav Shukla is a startup investor at Redpin Therapeutics.

## About Redpin Therapeutics

VC Fund · New York, United States

Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company wasfounded in 2017 and is headquartered in New York.

3 contacts available at Redpin Therapeutics.

| Name | Title | Profile |
| --- | --- | --- |
| Abhinav Shukla | Chief Technical Operations Officer | https://shizune.co/investors/profile/abhinav-shukla |
| David Bleakman | Chief Scientific Officer | https://shizune.co/investors/profile/david-bleakman |
| Elma Hawkins | President, CEO and Founder | https://shizune.co/investors/profile/elma-hawkins-f57a |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co